Company Overview and News

25
Skyworks' (SWKS) Q3 Earnings Beat, Weak Mobile Hurts Top Line

6h zacks
Skyworks Solutions Inc. (SWKS - Free Report) reported third-quarter fiscal 2018 non-GAAP earnings of $1.64 per share, which beat the Zacks Consensus Estimate as well as management guidance by a nickel. The figure improved 4.5% from the year-ago quarter. Revenues of $894.3 million were down 0.7% year over year, primarily due to weakness in mobile business and loss of ZTE revenues (which usually contributes $25-$30 million per quarter).
SWIR SWKS QRVO KDP GM.WS.A GM.WS.B GM.WS.C SW GM QCOM GM.WSB

7
Skyworks Solutions, Inc. (SWKS) CEO Liam Griffin on Q3 2018 Results - Earnings Call Transcript

16h seekingalpha
Good afternoon, and welcome to Skyworks Solutions' Third Quarter Fiscal Year 2018 Earnings Call. This call is being recorded. At this time, I will turn the call over to Mitch Haws, Vice President of Investor Relations for Skyworks. Mr. Haws please go ahead.
CHLKF MS.PRE MS.PRF SW MS.PRG MS.PRA 0941 SWIR SWKS 0762 MS.PRI CHL MS.PRK CHUFF MS CHU

6
TESSCO Technologies Incorporated (TESS) CEO Murray Wright on Q1 2019 Results - Earnings Call Transcript

2018-07-17 seekingalpha
Good day, ladies and gentlemen, and welcome to the First Quarter 2019 TESSCO Technologies Incorporated Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we'll conduct a question-and-answer session, and instructions will be given at that time. [Operator Instructions] As a reminder, this conference call is being recorded.
SWIR SW TESS

10
Sierra Delivers FirstNet Approved Router for Public Safety

2018-06-29 zacks
Sierra Wireless, Inc. (SWIR - Free Report) recently unveiled the new AirLink MG90 high-performance LTE-Advanced Pro multi-network vehicle router, designed specifically to provide secure and constant connectivity for mission critical applications. This is the first device to be deemed FirstNet Ready. Understanding FirstNet To better understand the motive behind Sierra’s newly-launched router, let us first talk about what FirstNet is.
SWIR MSI CMTL SW PII

6
SWIR / Sierra Wireless, Inc. SIERRA WIRELESS, INC. 6-K (Current Report of Foreign Issuer)

2018-06-28 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the Month of
SWIR

20
Financial Exchange Stock Talk: Kirk Spano On Intel And Sierra Wireless

2018-06-27 seekingalpha
We now partner with Financial Exchange Radio to produce a weekly segment with Seeking Alpha authors.
SWIR INTC

45
5 Cheap Internet of Things Stocks Poised for High Growth | InvestorPlace

2018-06-26 investorplace
Our connection to the internet took on a new and more involved form when much of the connectivity moved from the PC to the smartphone. This ushered in a whole host of applications that changed the way we live.
SWIR SWKS TXN ARW SW NYTAB MCHP INTC

9
Go Time For An Inseego Turnaround

2018-06-22 seekingalpha
Disclaimer: This material is furnished by Lerna Capital LLC or affiliates (collectively “Lerna”). This material is for information purposes only and is not an offer or a solicitation to subscribe for or purchase the securities mentioned. This material is not intended to provide a sufficient basis on which to make an investment decision. All market and commercial data in this thesis are not warranted as to completeness or accuracy.
SWIR INSG SW MIFI

93
Revamping Or Starting A Portfolio Now

2018-06-16 seekingalpha
Old economy, high capital, no moat is a catastrophe waiting to happen - sell your grandpa's stocks.
LMT NE NOBGF SPWR CAT TWX SW GOOG TWC EXAS SWIR ESV GOOGL N21 NOBGY NTR RIG

16
SWIR / Sierra Wireless, Inc. FORM 6-K (Current Report of Foreign Issuer)

2018-06-05 sec.gov
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION
SWIR

10
SWIR / Sierra Wireless, Inc. SIERRA WIRELESS, INC. 6-K (Current Report of Foreign Issuer)

2018-06-05 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the Month of
SWIR

74
Printing Money Selling Puts

2018-06-01 seekingalpha
Selling "cash-secured put options" is a PRO move that is easy, safer than buying stock and generates portfolio income.
OCLR SPWR CALX CTL SW ECA TTOO GME EXAS SWIR ECA HP LITE FSLR

14
SWIR / Sierra Wireless, Inc. SIERRA WIRELESS, INC. 6-K (Current Report of Foreign Issuer)

2018-05-31 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the Month of
SWIR

12
SWIR / Sierra Wireless, Inc. FORM SD

2018-05-31 sec.gov
Document
SWIR

11
SWIR / Sierra Wireless, Inc. SIERRA WIRELESS, INC. 6-K (Current Report of Foreign Issuer)

2018-05-18 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934 For the Month of
SWIR

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to SWIR / Sierra Wireless, Inc. on message board site Silicon Investor.

Sierra Wireless, Inc. (SWIR) Sierra Wireless (NASDAQ: SWIR)
Globetel and Sanswire BoardsWire
A Wall Street West Newswire Discussion Board Steve Swirskyu0027s PTSC Contrarian Message Board
CUSIP: 826516106